Coopidrogas billed $4.6 trillion in 2025 and reached 33.7% market share in units
2025 Sales: $4.6 trillion, with 14.6% annual growth. Photo: Courtesy
TL;DR
- Coopidrogas reported 2025 sales of $4.6 trillion, a 14.6% year-over-year increase.
- Market share reached 33.7% in units and 29.3% in value within the independent channel.
- Strategic drug categories such as antihypertensives, analgesics, and antidiabetics saw over 36% growth.
- The number of active drugstores increased to 10,159, with 1,587 new establishments joined.
- A new operational headquarters in Galapa, Atlántico, was inaugurated, requiring an investment over $108 billion.
- The Galapa facility enhanced regional capacity, handling 1,200 daily orders and moving over 30 million units annually.
- Coopidrogas employed 2,352 individuals and strengthened brand visibility through its 'Afiliada a Coopidrogas' program.
- Investments were made in the Manufacturing Plant, with a total projected cost of $26.445 billion.